Claraphi Advisory Network, LLC Charles River Laboratories International, Inc. Transaction History

Claraphi Advisory Network, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$351.38 - $448.68 $248,777 - $317,665	-708 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $263,829 - $324,476	708 New	708 $292,000
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $204,176 - $263,361	-1,163 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$118.84 - $189.72 $1,069 - $1,707	9 Added 0.78%	1,163 $203,000
Q1 2020 May 15, 2020	BUY	$98.9 - $178.34 $114,130 - $205,804	1,154 New	1,154 $146,000
Q2 2019 Jul 29, 2019	SELL	$123.4 - $148.55 $176,708 - $212,723	-1,432 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$104.82 - $146.73 $150,102 - $210,117	1,432 New	1,432 $208,000
Q4 2018 Feb 12, 2019	SELL	$105.09 - $137.23 $204,189 - $266,637	-1,943 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$112.11 - $134.54 $12,892 - $15,472	115 Added 6.29%	1,943 $262,000
Q2 2018 Aug 14, 2018	BUY	$102.37 - $117.25 $187,132 - $214,333	1,828 New	1,828 $206,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Claraphi Advisory Network, LLC with notifications on news.